Trial ID 21541 | Maryland Oncology Hematology Trial ID 21541 – Maryland Oncology Hematology

Trial ID 21541

Trial Information - Phase III

Tropion-Lung08: A Randomized, Open-label, Phase 3 Trial of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in Treatment-naïve Subjects with Advanced or Metastatic PD-L1 High (TPS ≥50%) Non-small Cell Lung Cancer Without Actionable Genomic Alterations

Disease Specifics: (NSCLC)

Protocol ID: DS1062-A-U304

Sponsor: Daiichi Sankyo, Inc

Status: PENDING OPEN

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Lung

Investigator

Juneja MD, Vinni

Status

PENDING OPEN

Sponsor

Daiichi Sankyo, Inc

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology